Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Simplex, Genital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01448616
What this trial is testing

Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding

Who this might be right for
Herpes Simplex Type II
University of Washington 73
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Not applicableStudy completedNCT00002000
What this trial is testing

Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

Who this might be right for
Herpes SimplexHIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)UnknownNCT00005663
What this trial is testing

Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Who this might be right for
Herpes SimplexHIV InfectionsHerpes Genitalis
Glaxo Wellcome
Not applicableStudy completedNCT00002021
What this trial is testing

An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

Who this might be right for
Herpes SimplexHIV Infections
Astra USA
Large-scale testing (Phase 3)Study completedNCT00001649
What this trial is testing

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT00233155
What this trial is testing

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

Who this might be right for
Herpes ZosterNeuralgiaPain+2 more
NeurogesX 100
Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Not applicableStudy completedNCT01315054
What this trial is testing

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Who this might be right for
HIVHepatitis CSyphilis+1 more
Centers for Disease Control and Prevention 4,258
Large-scale testing (Phase 3)Study completedNCT00306787
What this trial is testing

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Who this might be right for
Genital Herpes
Novartis Pharmaceuticals 1,179
Testing effectiveness (Phase 2)Study completedNCT02030301
What this trial is testing

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Who this might be right for
Genital Herpes Simplex Type 2
Vical 165
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Early research (Phase 1)Study completedNCT00002144
What this trial is testing

The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment

Who this might be right for
Herpes SimplexHIV Infections
Astra USA 12
Not applicableStudy completedNCT02053142
What this trial is testing

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Who this might be right for
Ulcers of Female Genital Organs
University of North Carolina, Chapel Hill 74
Testing effectiveness (Phase 2)Study completedNCT04165122
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Who this might be right for
Herpes Genitalis
Heidelberg ImmunoTherapeutics GmbH 122
Not applicableStudy completedNCT00002181
What this trial is testing

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

Who this might be right for
Herpes SimplexHIV Infections
Gilead Sciences
Not applicableStudy completedNCT00946556
What this trial is testing

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

Who this might be right for
Herpes Simplex Type Two InfectionHIV Infections
University of Toronto 30
Post-approval studies (Phase 4)Study completedNCT00527618
What this trial is testing

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Who this might be right for
Genital HerpesHIV Infection
University of Washington 28
Early research (Phase 1)Ended earlyNCT04222985
What this trial is testing

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

Who this might be right for
Genital Herpes
Sanofi Pasteur, a Sanofi Company 24
Next Page